rs660895 — HLA-DRB1

HLA-DRB1*04:01 — The Shared Epitope and Rheumatoid Arthritis Risk

The human leukocyte antigen (HLA) region on chromosome 6 is the single largest genetic risk factor for rheumatoid arthritis (RA), and within it the HLA-DRB1 gene dominates. rs660895 is a regulatory tag SNP that travels almost exclusively with the HLA-DRB1*04:01 allele¹¹ HLA-DRB1*04:01 allele
HLA alleles encode the antigen-binding groove of class II molecules; *04:01 is one of the alleles carrying the "shared epitope" motif at positions 70–74 of the beta chain. The G allele marks this high-risk haplotype; homozygosity for G roughly doubles the shared-epitope dose and substantially amplifies RA risk and severity.

The Mechanism

HLA-DRB1 encodes the beta chain of a class II MHC molecule that sits on the surface of antigen-presenting cells and presents peptide fragments to CD4+ T cells. The shared epitope is a five-amino-acid sequence (QKRAA, QRRAA, or RRRAA) in the peptide-binding groove²² peptide-binding groove
specifically at positions 70–74 of the DRβ1 hypervariable region-3. This motif is particularly efficient at binding and displaying citrullinated peptides — proteins where arginine residues have been chemically modified (citrullinated) by the enzyme PAD4. CD4+ T cells recognising these citrullinated epitopes drive B cells to produce anti-citrullinated protein antibodies (ACPA/anti-CCP), the hallmark autoantibody of seropositive RA. The SE alleles explain roughly 18% of the genetic variance in ACPA-positive RA — by far the largest single-locus contribution of any common variant.

The Evidence

Disease susceptibility. The SE gene-dose effect on ACPA-positive RA susceptibility is one of the most replicated findings in autoimmune genetics. Barra et al. 2010³³ Barra et al. 2010
HLA-DRB1 Genotypes and the Risk of Developing ACPA-Positive RA. PLOS One 2013; genotypic ORs ranging from 0.19 to 28 across DRB1 alleles in 857 cases showed a gradient from strongly protective to highly susceptible alleles, with *04:01 conferring among the highest ORs.

Joint damage progression. rs660895 does more than predict susceptibility — it predicts how fast joints will erode. In the CARDERA trial cohort (524 early RA patients followed for 2 years), Canhão et al. 2015⁴⁴ Canhão et al. 2015
Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis? J Rheumatol 2015 found that each G allele of rs660895 was associated with a 1.07-fold greater annual increase in Larsen radiographic score (p=0.0003). Critically, this association held only in ACPA-positive patients (β=1.08, p=0.011); no effect was seen in ACPA-negative patients (β=1.04, p=0.43). A subsequent meta-analysis of seven RA radiographic GWAS⁵⁵ meta-analysis of seven RA radiographic GWAS
Genetic associations with radiological damage in RA: meta-analysis of 2,775 cases. Arthritis Res Ther 2019 confirmed rs660895 as the most consistently replicated genetic predictor of joint damage.

Extra-articular disease. Turesson et al. 2004⁶⁶ Turesson et al. 2004
Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004 found that rs660895(G;G) homozygotes had an odds ratio of 6.2 (CI 1.01–37.9) for rheumatoid vasculitis, one of the most severe extra-articular manifestations of RA.

Treatment response. Yilmaz et al. 2024⁷⁷ Yilmaz et al. 2024
Association of HLA-DRB1 with treatment response to abatacept or TNF inhibitors in seropositive RA. Sci Rep 2024 found that SE-positive (G-allele) patients responded better to abatacept (a CTLA4-Ig that blocks T-cell co-stimulation) than to TNF inhibitors. This suggests rs660895 genotype can help rheumatologists choose between biologic classes in seropositive RA.

Practical Actions

Carrying one or two G alleles does not mean RA is inevitable — lifestyle and environmental factors (notably smoking, which dramatically amplifies SE risk) are co-required triggers. However, G carriers who are ACPA-positive have substantially higher odds of rapid radiographic progression and should pursue aggressive disease management early. ACPA testing and baseline hand/feet X-rays (or ultrasound/MRI) are the key monitoring tools. If RA does develop, rheumatologists should be aware that SE-positive patients may respond preferentially to abatacept over TNF inhibitors. Smoking cessation is uniquely important in G-allele carriers because gene-environment interaction with smoking multiplies RA risk superadditively.

Interactions

rs660895 acts in the same antigen-presentation pathway as rs2476601 (PTPN22 R620W), the second largest RA risk locus. When both are present (a common scenario given both are relatively frequent), RA risk is multiplicative rather than additive — each amplifies T-cell autoreactivity through distinct mechanisms (peptide presentation vs. T-cell receptor signalling). The interaction between SE alleles and rs2476601 has been confirmed in multiple large European cohorts.

The G allele also shows a protective association with Parkinson's disease (PD): in a meta-analysis of 44,451 individuals⁸⁸ meta-analysis of 44,451 individuals
Hamza et al. Mov Disord 2012, rs660895-G was associated with reduced PD risk (OR 0.86), suggesting HLA-DRB1*04:01 confers an immune-surveillance benefit against alpha-synuclein accumulation.